Future Goals

Breast cancer costs the U.S. healthcare system an estimated $5 billion a year with a large portion of that figure attributable to the cost of diagnosing and monitoring the disease. There are 8,800 facilities in the U.S. with the ability to provide digital mammography tests and each facility can perform more than 25,000 procedures per year. Incorporating the LifeScreen test into the regimen would provide a large market for our proprietary technology.